220 related articles for article (PubMed ID: 24121548)
1. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
Kouri N; Carlomagno Y; Baker M; Liesinger AM; Caselli RJ; Wszolek ZK; Petrucelli L; Boeve BF; Parisi JE; Josephs KA; Uitti RJ; Ross OA; Graff-Radford NR; DeTure MA; Dickson DW; Rademakers R
Acta Neuropathol; 2014 Feb; 127(2):271-82. PubMed ID: 24121548
[TBL] [Abstract][Full Text] [Related]
2. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
3. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.
Karch CM; Kao AW; Karydas A; Onanuga K; Martinez R; Argouarch A; Wang C; Huang C; Sohn PD; Bowles KR; Spina S; Silva MC; Marsh JA; Hsu S; Pugh DA; Ghoshal N; Norton J; Huang Y; Lee SE; Seeley WW; Theofilas P; Grinberg LT; Moreno F; McIlroy K; Boeve BF; Cairns NJ; Crary JF; Haggarty SJ; Ichida JK; Kosik KS; Miller BL; Gan L; Goate AM; Temple S;
Stem Cell Reports; 2019 Nov; 13(5):939-955. PubMed ID: 31631020
[TBL] [Abstract][Full Text] [Related]
5. A novel tau mutation, p.K317N, causes globular glial tauopathy.
Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
7. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
8. A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.
Tacik P; DeTure M; Hinkle KM; Lin WL; Sanchez-Contreras M; Carlomagno Y; Pedraza O; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
J Neuropathol Exp Neurol; 2015 Nov; 74(11):1042-52. PubMed ID: 26426266
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
[TBL] [Abstract][Full Text] [Related]
10. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
[TBL] [Abstract][Full Text] [Related]
12. Exon 3 insert of tau protein in neurodegenerative diseases.
Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
[TBL] [Abstract][Full Text] [Related]
13. The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.
Iovino M; Pfisterer U; Holton JL; Lashley T; Swingler RJ; Calo L; Treacy R; Revesz T; Parmar M; Goedert M; Muqit MM; Spillantini MG
Acta Neuropathol; 2014 Feb; 127(2):283-95. PubMed ID: 24292008
[TBL] [Abstract][Full Text] [Related]
14. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
15. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.
Razquin C; Ortega-Cubero S; Rojo-Bustamante E; Diez-Fairen M; Lorenzo E; Alonso E; Ezquerra M; Ross OA; Carcel M; Lorenzo-Betancor O; Soto AI; Burgess JD; Ertekin-Taner N; Dickson DW; Pastor MA; Tolosa E; Pastor P
Neurobiol Aging; 2018 Jun; 66():177.e7-177.e10. PubMed ID: 29398119
[TBL] [Abstract][Full Text] [Related]
16. Haplotype-specific expression of exon 10 at the human MAPT locus.
Caffrey TM; Joachim C; Paracchini S; Esiri MM; Wade-Martins R
Hum Mol Genet; 2006 Dec; 15(24):3529-37. PubMed ID: 17085483
[TBL] [Abstract][Full Text] [Related]
17. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7.
Kovacs GG; Wöhrer A; Ströbel T; Botond G; Attems J; Budka H
Clin Neuropathol; 2011; 30(1):3-10. PubMed ID: 21176711
[TBL] [Abstract][Full Text] [Related]
18. Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.
Stanford PM; Brooks WS; Teber ET; Hallupp M; McLean C; Halliday GM; Martins RN; Kwok JB; Schofield PR
J Neurol; 2004 Sep; 251(9):1098-104. PubMed ID: 15372253
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
[TBL] [
